GeneID: 113



Names

Common Name: NFATC2 Type: Gene
Chromosome: 20 (NC_000020.11) Locus: N/A
HUGO Symbol: NFATC2 Full Name: nuclear factor of activated T-cells 2
Exons: 11 Introns: 10

Description:
NFATC2 is a member of the nuclear factor of activated T cell (NFAT) family of transcription factors that are regulated by the Ca2+/calcineurin pathway. NFATs are cytosolic proteins composed of a highly-conserved DNA-binding domain and the NFAT homology region (NHR). In resting cells the serine-rich NHR region is phosphorylated. Stimulation of receptors coupled to the Ca2+ signalling pathway activates the phosphatase calcineurin, which in turn dephosphorylates NFATs and mediates their translocation to the nucleus, where they modulate target gene transcription. NFATC2 is predominant in peripheral T lymphocytes and appears to control several immunoregulatory genes that are implicated in diverse immune functions, including thymocyte development, T cell differentiation and self-tolerance, cell-cycle progression and activation-induced apoptosis. Polymorphisms in this gene associated with acute chest syndrome, a type of severe vaso-occlusive episode, in sickle cell patients. Alternate transcriptional splice variants encoding different isoforms have been characterized.

Synonyms: NFAT1 , NFATP

Comments:
N/A

Number of entries/variants: 1

IthaScore

Sequence Viewer

Note: The NCBI Sequence Viewer is not installed on the ITHANET servers but it is embedded in this page from the NCBI. Therefore, IthaGenes has no responsibility over any temporary unavailability of the service. In such a case, please Refresh the page or retry at a later stage.

Publications / Origin

  1. Macian F, NFAT proteins: key regulators of T-cell development and function., Nat. Rev. Immunol. , 5(6), 472-84, 2005 PubMed
  2. Galarneau G, Coady S, Garrett ME, Jeffries N, Puggal M, Paltoo D, Soldano K, Guasch A, Ashley-Koch AE, Telen MJ, Kutlar A, Lettre G, Papanicolaou GJ, Gene-centric association study of acute chest syndrome and painful crisis in sickle cell disease patients., Blood , 122(3), 434-42, 2013 PubMed
Created on 2016-04-27 12:54:34, Last reviewed on (Show full history)


Disclaimer: The information on this website is provided as an information resource only and must not to be used as a substitute for professional diagnosis and treatment. The ITHANET Portal and IthaGenes are not responsible or liable for any advice, course of treatment, diagnosis or any other information, services or products that an individual obtains through this website.